logo for Acrivon Therapeutics

Acrivon Therapeutics

Business Services · Massachusetts, United States · 58 Employees

View Company Info for Free

About

Headquarters

480 Arsenal Way Ste 100, Watertown, Massachuset...

Phone Number

(617) 207-8979

Revenue

$70.4 Million

Stock Symbol

ACRV

Industry

Business Services General Business Services

Highlights

$100M

Total Funding Amount

$100M

Most Recent Funding Amount

1

Number of Funding Rounds

View details

Who is Acrivon Therapeutics

Acrivon Therapeutics is a precision oncology therapeutics company uniquely enabled by a differentiated proteomics-based patient selection platform. Our method is widely applicable across drug classes and modalities. We specifically apply our approach to challenging oncology drug targets causally implicated in the vast majority of cancers, particularly those without simple single gene driver mutations or synthetic lethal contexts. Leveraging our unique patient selection platform, Acrivon Therapeutics aims to rapidly progress in-licensed clinical-stage assets and a pipeline of internally developed programs through accelerated registration trials. Acrivon Therapeutics and its clinical biomarker development group is headquartered in the greater Boston area, with biomarker discovery efforts concentrated in our wholly-owned subsidiary in Lund, Sweden.Explore more
Acrivon Therapeutics's Social MediaPopular SearchesAcrivon TherapeuticsACRIVON THERAPEUTICS IncAcrivonAcrivon AbAcrivon Securities CorpSIC Code 87,873NAICS Code 54,541Ticker NASDAQ: ACRVShow more

Acrivon Therapeutics Org Chart

Peter Blume-Jensen

Chief Executive Officer, President & Founder ...

PhoneEmail
Eric Devroe

Chief Operating Officer

PhoneEmail
Jean-Marie Cuillerot

Chief Medical Officer

PhoneEmail

PhoneEmail

Is Acrivon Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Acrivon Therapeutics

Compare insights from companies similar to Acrivon Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Acrivon Therapeutics

$70.4M
58
Placeholder for Top Executive
$95.5M
49
Placeholder for Top Executive
$6.3M
30
Placeholder for Top Executive
Illustration of an envelope

Acrivon Therapeutics financials insights

Gather financial insights about Acrivon Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

Acrivon Therapeutics Employee Growth Rate

Graph showing projected employee growth data for Acrivon Therapeutics

View Acrivon Therapeutics’s full employee growth data

Percentage of growth

1st year Mask

2nd year Mask

Acrivon Therapeutics Tech Stack

A closer look at the technologies used by Acrivon Therapeutics

Most Recent Scoops

Earnings
Earnings
Earnings
Product Development, Research & Development
Earnings
Earnings
Financial Planning, Funding
See more scoops

Acrivon Therapeutics News & Media

Read more news

Top Companies in United States

Top 10 companies in United States by revenue

Top 10 companies in United States by number of employees

Top 10 companies in United States by total funding amount

See top companies

Frequently Asked Questions Regarding Acrivon Therapeutics

Where is Acrivon Therapeutics located?
Acrivon Therapeutics's headquarters are located at 480 Arsenal Way Ste 100, Watertown, Massachusetts, 02472, United States
What is Acrivon Therapeutics's phone number?
Acrivon Therapeutics's phone number is (617) 207-8979
What is Acrivon Therapeutics's stock symbol?
Acrivon Therapeutics's stock symbol is ACRV
What is Acrivon Therapeutics's official website?
Acrivon Therapeutics's official website is www.acrivon.com
What is Acrivon Therapeutics's Revenue?
Acrivon Therapeutics's revenue is $70.4 Million
What is Acrivon Therapeutics's SIC code?
Acrivon Therapeutics's SIC: 87,873
What is Acrivon Therapeutics's NAICS code?
Acrivon Therapeutics's NAICS: 54,541
How many employees does Acrivon Therapeutics have?
Acrivon Therapeutics has 58 employees
What industry does Acrivon Therapeutics belong to?
Acrivon Therapeutics is in the industry of: Business Services General, Business Services
What is Acrivon Therapeutics competition?
Acrivon Therapeutics top competitors include: Strata Oncology, TYRA, Translational Drug Development (TD2), KSQ Therapeutics
What technology does Acrivon Therapeutics use?
Some of the popular technologies that Acrivon Therapeutics uses are: WordPress.org, PHP, Cloudflare Website Optimization, Cloudflare CDN
Who is the CEO of Acrivon Therapeutics?
Acrivon Therapeutics's CEO is Peter Blume-Jensen
How do I contact Acrivon Therapeutics?
Acrivon Therapeutics contact info: Phone number: (617) 207-8979 Website: www.acrivon.com
What does Acrivon Therapeutics do?

Acrivon Therapeutics is a precision oncology therapeutics company uniquely enabled by a differentiated proteomics-based patient selection platform. Our method is widely applicable across drug classes and modalities. We specifically apply our approach to challenging oncology drug targets causally implicated in the vast majority of cancers, particula... rly those without simple single gene driver mutations or synthetic lethal contexts. Leveraging our unique patient selection platform, Acrivon Therapeutics aims to rapidly progress in-licensed clinical-stage assets and a pipeline of internally developed programs through accelerated registration trials. Acrivon Therapeutics and its clinical biomarker development group is headquartered in the greater Boston area, with biomarker discovery efforts concentrated in our wholly-owned subsidiary in Lund, Sweden.Read More

What are Acrivon Therapeutics social media links?
Acrivon Therapeutics Linkedin page
How much funding has Acrivon Therapeutics raised to date?
Acrivon Therapeutics has raised $100 Million in 1 funding round
When was the last funding round for Acrivon Therapeutics?
Acrivon Therapeutics closed its last funding round on Nov 11, 2022 with the amount of $100 Million
Who invested in Acrivon Therapeutics?
Acrivon Therapeutics has 4 investors including RA Capital Management, Surveyor Capital, Perceptive Advisors and Wellington Management.
Is Acrivon Therapeutics a public company?
Yes, Acrivon Therapeutics is a public company and is traded under the symbol ACRV
See more information about Acrivon Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.